Xometry (Xometry) Cash And Cash Equivalents : $53.4 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Xometry Cash And Cash Equivalents?

Xometry's quarterly cash and cash equivalents declined from Jun. 2023 ($56.74 Mil) to Sep. 2023 ($44.37 Mil) but then increased from Sep. 2023 ($44.37 Mil) to Dec. 2023 ($53.42 Mil).

Xometry's annual cash and cash equivalents declined from Dec. 2021 ($86.26 Mil) to Dec. 2022 ($65.66 Mil) and declined from Dec. 2022 ($65.66 Mil) to Dec. 2023 ($53.42 Mil).

Xometry Cash And Cash Equivalents Historical Data

The historical data trend for Xometry's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xometry Cash And Cash Equivalents Chart

Xometry Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

40.12

59.87

86.26

65.66

53.42

Xometry Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial												65.66	39.71	56.74	44.37	53.42

Xometry Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Xometry (NAS:XMTR) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Xometry Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Xometry's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Xometry (Xometry) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Xometry Inc (NAS:XMTR) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

0N5:Germany

Address

6116 Executive Boulevard, Suite 800, North Bethesda, MD, USA, 20855

Website

https://www.xometry.com

Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as: (1) the U.S. and (2) International. The majority of the revenue is earned from the U.S. segment.

Executives

James M Rallo	officer: Chief Financial Officer	C/O LIQUIDITY SERVICES INC., 1920 L STREET, N.W., 6TH FLOOR, WASHINGTON DC 20036
Matthew Leibel	officer: Chief Technology Officer	7529 STANDISH PLACE, SUITE 200, CO XOMETRY, INC., DERWOOD MD 20855
Bill Cronin	officer: Chief Revenue Officer	180 CONCORD DRIVE, MADISON CT 06824
Emily Rollins	director	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Peter Goguen	officer: Chief Operating Officer	7529 STANDISH PLACE, SUITE 200, DERWOOD MD 20855
George Hornig	director	C/O CREDIT SUISSE FIRST BOSTON PRIVATE, 11 MADISON AVE, NEW YORK NY 10010
Katharine Weymouth	director	1300 NORTH 17TH STREET, SUITE 1700, ARLINGTON VA 22209
Randolph Altschuler	director, officer: Chief Executive Officer	7529 STANDISH PLACE, SUITE 200, DERWOOD MD 20855
Laurence Zuriff	director, officer: Chief Strategy Officer	7529 STANDISH PLACE, SUITE 200, DERWOOD MD 20855
Kathy Mayerhofer	officer: Chief Sales Officer	7529 STANDISH PLACE, SUITE 200, DERWOOD CA 20855
Highland Leaders Fund I, L.p.	10 percent owner	ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142
Highland Leaders Fund I Gp, Llc	10 percent owner	ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142
Highland Leaders Fund I Gp, L.p.	10 percent owner	ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142
Highland Capital Partners 9 Limited Partnership	10 percent owner	ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142
Highland Capital Partners 9-b Limited Partnership	10 percent owner	ONE BROADWAY, 16TH FLOOR, CAMBRIDGE MA 02142